BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18085394)

  • 1. Fatal diffuse pulmonary arterial thrombosis as a complication of nephrotic syndrome.
    Matsuda A; Tsuchiya K; Yabuki Y; Naito M; Koike M; Yumura W; Nitta K
    Clin Exp Nephrol; 2007 Dec; 11(4):316-320. PubMed ID: 18085394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute arterial thrombosis with antithrombin III deficiency in nephrotic syndrome: report of a case.
    Nishimura M; Shimada J; Ito K; Kawachi H; Nishiyama K
    Surg Today; 2000; 30(7):663-6. PubMed ID: 10930236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Femoral arterial thrombosis in nephrotic syndrome. Steroid and long term heparin therapy.
    Nitatori T; Niitu K; Kudoh S; Satoh Y; Abe K
    J Cardiovasc Surg (Torino); 1987; 28(2):189-92. PubMed ID: 3558470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic profile in nephrotic syndrome.
    Anand NK; Chand G; Talib VH; Chellani H; Pande J
    Indian Pediatr; 1996 Dec; 33(12):1005-12. PubMed ID: 9141800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercoagulability and nephrotic syndrome.
    Gigante A; Barbano B; Sardo L; Martina P; Gasperini ML; Labbadia R; Liberatori M; Amoroso A; Cianci R
    Curr Vasc Pharmacol; 2014 May; 12(3):512-7. PubMed ID: 22724465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary arterial thrombosis in a neonate with homozygous deficiency of antithrombin III: successful outcome following pulmonary thrombectomy and infusions of antithrombin III concentrate.
    Roman K; Rosenthal E; Razavi R
    Cardiol Young; 2000 May; 10(3):275-8. PubMed ID: 10824912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
    Kanbak M; Oc B; Salman MA; Ocal T; Oc M
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
    Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
    Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior sagittal sinus thrombosis in a child with nephrotic syndrome.
    Divekar AA; Ali US; Ronghe MD; Singh AR; Dalvi RB
    Pediatr Nephrol; 1996 Apr; 10(2):206-7. PubMed ID: 8703714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices.
    Adatya S; Sunny R; Fitzpatrick MJ; Colvin M; Thennapan T; John R; Dodge Zantek N; Pritzker M; Eckman P; Uriel N
    J Heart Lung Transplant; 2016 Nov; 35(11):1311-1320. PubMed ID: 27836023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotic syndrome complicated by life-threatening pulmonary embolism in an adult patient.
    Chen SC; Liu WC; Lee CH; Chang JM; Chen HC
    Kaohsiung J Med Sci; 2010 Feb; 26(2):89-95. PubMed ID: 20123597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombosis of the inferior vena cava with successive lung embolization in a 15-year-old boy with nephrotic syndrome].
    Janda J; Zábrodský V; Spatenka J; Tůma S
    Padiatr Padol; 1986; 21(1):69-74. PubMed ID: 3960565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased sensitivity to heparin in vitro in steroid-responsive nephrotic syndrome.
    Vermylen CG; Levin M; Lanham JG; Hardisty RM; Barratt TM
    Kidney Int; 1987 Jun; 31(6):1396-401. PubMed ID: 3613410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.
    Kessel AD; Kline M; Zinger M; McLaughlin D; Silver P; Sweberg TM
    J Intensive Care Med; 2017 Jan; 32(1):59-67. PubMed ID: 26319579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery.
    Oladunjoye OO; Sleeper LA; Nair AG; Trenor CC; VanderPluym C; Kheir JN; Emani SM
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):332-340.e1. PubMed ID: 29709361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro.
    Raaz U; Kaeberich A; Maegdefessel L; Buerke M; Busshardt M; Schubert S; Russ M; Plehn A; Ebelt H; Werdan K; Schlitt A
    Thromb Haemost; 2010 Apr; 103(4):808-14. PubMed ID: 20174756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.